Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
- PMID: 30366316
- DOI: 10.1016/j.bioorg.2018.10.023
Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
Abstract
A novel series of quinazolinone-1,2,3-triazole hybrids 10a-p were designed, synthesized, and evaluated for their in vitro α-glucosidase inhibitory activity leading to efficient anti-diabetic agents. All synthesized compounds exhibited good inhibitory activity against yeast α-glucosidase (IC50 values in the range of 181.0-474.5 µM) even much more potent than standard drug acarbose (IC50 = 750.0). Among them, quinazolinone-1,2,3-triazoles possessing 4-bromobenzyl moiety connected to 1,2,3-triazole ring (10g and 10p) demonstrated the most potent inhibitory activity towards α-glucosidase. Compound 10g inhibited α-glucosidase in a competitive manner with Ki value of 117 µM. Furthermore, the binding modes of the most potent compounds 10g and 10p in the α-glucosidase active site was studied through in silico docking studies. Also, lack of cytotoxicity of compounds 10g and 10p was confirmed via MTT assay.
Keywords: 1,2,3-Triazole; Anti-diabetic activity; Competitive inhibition; Molecular docking; Quinazolinone; α-Glucosidase.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.Bioorg Chem. 2019 Nov;92:103206. doi: 10.1016/j.bioorg.2019.103206. Epub 2019 Aug 16. Bioorg Chem. 2019. PMID: 31445191
-
Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.Eur J Med Chem. 2019 Aug 15;176:343-377. doi: 10.1016/j.ejmech.2019.04.025. Epub 2019 Apr 30. Eur J Med Chem. 2019. PMID: 31112894 Review.
-
Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.Med Chem. 2019;15(1):8-16. doi: 10.2174/1573406414666180528110104. Med Chem. 2019. PMID: 29807519 Review.
-
Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.Bioorg Chem. 2018 Apr;77:280-286. doi: 10.1016/j.bioorg.2018.01.025. Epub 2018 Feb 3. Bioorg Chem. 2018. PMID: 29421703
-
Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.Eur J Med Chem. 2017 Jan 5;125:423-429. doi: 10.1016/j.ejmech.2016.09.067. Epub 2016 Sep 21. Eur J Med Chem. 2017. PMID: 27689725
Cited by
-
Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.Sci Rep. 2024 Jan 3;14(1):388. doi: 10.1038/s41598-023-50395-8. Sci Rep. 2024. PMID: 38172167 Free PMC article.
-
Diversity-oriented synthesis of 1H-1,2,3-triazole tethered pyrazolo[5,1-b]quinazoline hybrids as antimicrobial agents.Mol Divers. 2023 Sep 11. doi: 10.1007/s11030-023-10721-8. Online ahead of print. Mol Divers. 2023. PMID: 37697023
-
Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles.Parasitol Res. 2023 Oct;122(10):2353-2365. doi: 10.1007/s00436-023-07936-x. Epub 2023 Aug 23. Parasitol Res. 2023. PMID: 37610452 Free PMC article.
-
Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-One-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity.Int J Mol Sci. 2023 Jul 3;24(13):11044. doi: 10.3390/ijms241311044. Int J Mol Sci. 2023. PMID: 37446224 Free PMC article.
-
Recent Advances in the Green Synthesis of Active N-Heterocycles and Their Biological Activities.Pharmaceuticals (Basel). 2023 Jun 13;16(6):873. doi: 10.3390/ph16060873. Pharmaceuticals (Basel). 2023. PMID: 37375820 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
